FindTrial
Sign In

Study on the Correlation between HBV Drug Resistance and Drug Concentration in Patients with Low Viremia Chronic Hepatitis B

Study on the Correlation between HBV Drug Resistance and Drug Concentration in Patients with Low Viremia Chronic Hepatitis B

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099114
Enrollment
Unknown
Registered
2025-03-18
Start date
2025-03-20
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic hepatitis B

Interventions

experimental group:None
control group:None

Sponsors

The Third Affiliated Hospital Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Cases clinically diagnosed with HBV virus infection and treated with first-line antiviral drugs (ETV, TDF, etc.) TAF/TMF treatment for >= 48 weeks. 2.(2) Age >= 18 years old;

Exclusion criteria

Exclusion criteria: 1.Patients with combined HCV or HIV infections. 2.Patients who are currently taking other medications.

Design outcomes

Primary

MeasureTime frame
Concentration of antiviral drugs for hepatitis B;—

Secondary

MeasureTime frame
HBV drug resistance gene mutation;—

Countries

China

Contacts

Public ContactZhangka

The Third Affiliated Hospital Sun Yat-sen University

zhangka2@mail.sysu.edu.cn+86 20 85253571

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026